LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 228 filers reported holding LOXO ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $42,593,000 | +11.5% | 304,086 | +36.0% | 0.02% | +61.5% |
| Q3 2018 | $38,206,000 | +0.5% | 223,647 | +2.1% | 0.01% | -23.5% |
| Q2 2018 | $38,013,000 | -4.0% | 219,121 | -36.1% | 0.02% | -5.6% |
| Q1 2018 | $39,582,000 | +537.4% | 343,080 | +365.1% | 0.02% | +500.0% |
| Q4 2017 | $6,210,000 | -47.0% | 73,760 | -42.0% | 0.00% | -50.0% |
| Q3 2017 | $11,725,000 | +7.7% | 127,266 | -6.3% | 0.01% | +20.0% |
| Q2 2017 | $10,887,000 | +692.9% | 135,776 | +316.1% | 0.01% | +400.0% |
| Q1 2017 | $1,373,000 | +22.4% | 32,634 | -6.6% | 0.00% | 0.0% |
| Q4 2016 | $1,122,000 | -18.5% | 34,940 | -41.1% | 0.00% | 0.0% |
| Q2 2016 | $1,376,000 | -21.0% | 59,357 | -6.8% | 0.00% | 0.0% |
| Q1 2016 | $1,742,000 | – | 63,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |